Growth Metrics

INSMED (INSM) EBIT: 2009-2013

Historic EBIT for INSMED (INSM) over the last 5 years, with Dec 2013 value amounting to -$55.0 million.

  • INSMED's EBIT fell 175.92% to -$22.8 million in Q2 2014 from the same period last year, while for Jun 2014 it was -$73.3 million, marking a year-over-year decrease of 74.96%. This contributed to the annual value of -$55.0 million for FY2013, which is 29.64% down from last year.
  • As of FY2013, INSMED's EBIT stood at -$55.0 million, which was down 29.64% from -$42.4 million recorded in FY2012.
  • Over the past 5 years, INSMED's EBIT peaked at -$8,092 during FY2010, and registered a low of -$61.7 million during FY2011.
  • Moreover, its 3-year median value for EBIT was -$55.0 million (2013), whereas its average is -$53.1 million.
  • As far as peak fluctuations go, INSMED's EBIT slumped by 762,616.26% in 2011, and later soared by 31.24% in 2012.
  • Over the past 5 years, INSMED's EBIT (Yearly) stood at -$8,674 in 2009, then rose by 6.71% to -$8,092 in 2010, then crashed by 762,616.26% to -$61.7 million in 2011, then spiked by 31.24% to -$42.4 million in 2012, then decreased by 29.64% to -$55.0 million in 2013.